Broadfin Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Broadfin Capital’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$27.2M	Hold	4,300,066	–	–	3.64%	5
2019 Q3	$18.1M	Buy	4,300,066 +18,123	+0.4%	+$77.4K	3.35%	7
2019 Q2	$19.9M	Sell	4,281,943 -93,123	-2%	-$434K	4.33%	7
2019 Q1	$23.2M	Hold	4,375,066	–	–	4.79%	5
2018 Q4	$16.2M	Hold	4,375,066	–	–	2.13%	13
2018 Q3	$12.3M	Buy	4,375,066 +96,247	+2%	+$270K	1.8%	22
2018 Q2	$12.6M	Hold	4,278,819	–	–	1.99%	18
2018 Q1	$9.63M	Sell	4,278,819 -355,300	-8%	-$832K	1.5%	22
2017 Q4	$13.7M	Buy	4,634,119 +223,253	+5%	+$617K	2.23%	19
2017 Q3	$13M	Sell	4,410,866 -711,228	-14%	-$2.17M	1.92%	18
2017 Q2	$14.3M	Sell	5,122,094 -276,700	-5%	-$584K	1.74%	20
2017 Q1	$10.3M	Hold	5,398,794	–	–	1.24%	28
2016 Q4	$9.45M	Buy	5,398,794 +210,000	+4%	+$429K	1.05%	27
2016 Q3	$14M	Hold	5,188,794	–	–	1.26%	23
2016 Q2	$12.2M	Hold	5,188,794	–	–	1.19%	23
2016 Q1	$16.8M	Buy	5,188,794 +500,000	+11%	+$1.85M	1.62%	16
2015 Q4	$22.5M	Sell	4,688,794 -55,266	-1%	-$313K	1.38%	16
2015 Q3	$26.4M	Buy	4,744,060 +1,200,000	+34%	+$8.86M	1.47%	13
2015 Q2	$28.2M	Buy	3,544,060 +1,297,661	+58%	+$11.2M	1.52%	15
2015 Q1	$23.6M	Sell	2,246,399 -150,000	-6%	-$2.05M	1.84%	11
2014 Q4	$28.8M	Buy	2,396,399 +363,964	+18%	+$5.53M	2.5%	9
2014 Q3	$34.7M	Sell	2,032,435 -1,339,619	-40%	-$19.4M	3.64%	8
2014 Q2	$40.7M	Sell	3,372,054 -100,000	-3%	-$948K	3.97%	5
2014 Q1	$29.3M	Buy	3,472,054 +1,250,000	+56%	+$10.1M	2.84%	8
2013 Q4	$13.1M	Buy	2,222,054 +100,000	+5%	+$515K	1.73%	23
2013 Q3	$11.5M	Hold	2,122,054	–	–	2.05%	18
2013 Q2	$8.62M	Buy	+2,122,054	New	+$9.96M	1.69%	23

Other funds holding BDSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Broadfin Capital's BDSI Position: Q4 2019 in Review

Broadfin Capital held its BioDelivery Sciences International, Inc. (BDSI) position steady in Q4 2019 at 4,300,066 shares worth $27.2M. The position accounts for 3.64% of the portfolio, ranked #5.

Broadfin Capital first reported a position in BDSI in Q2 2013 and has held it in 27 quarters since. The position peaked at $40.7M in Q2 2014. 157 funds tracked by Wall St. Rank hold BDSI as of Q4 2019.

Broadfin Capital held 4,300,066 shares of BioDelivery Sciences International, Inc. worth $27.2M as of Q4 2019.
Broadfin Capital left its BioDelivery Sciences International, Inc. share count unchanged in Q4 2019.
BioDelivery Sciences International, Inc. made up 3.64% of Broadfin Capital's portfolio in Q4 2019, its #5 holding.
Broadfin Capital first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and has held it in 27 quarters since.
Broadfin Capital's BioDelivery Sciences International, Inc. position peaked at $40.7M in Q2 2014.
157 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2019.

Based on Broadfin Capital's 13F filing for Q4 2019, filed 14 Feb 2020.